MarketPulse

immuno-oncology

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Checkpoint Inhibitor Market Analysis: 50+ Players Drive Immuno-Oncology Innovation Through 2026

Over 50 companies compete in the checkpoint inhibitor market with 60+ drug candidates in development. Major consolidation and innovation drive immuno-oncology growth through 2026.
BMYCELGrKYKOYRNAZclinical trialscompetitive landscape
BenzingaBenzinga··Globe Newswire

Liminatus Pharma Prices $4M Share Offering to Fund Immuno-Oncology Pipeline

Liminatus Pharma prices $4M share offering to fund immuno-oncology pipeline development, specifically advancing CD47-blockade therapeutic programs.
LIMNLIMNWwarrantspublic offering